Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL

Roberts, ZJ; Better, M; Bot, A; Roberts, MR; Ribas, A

Ribas, A (reprint author), Univ Calif Los Angeles, Dept Med, Jonsson Comprehens Canc Ctr, 11-934 Factor Bldg,10833 Le Conte Ave, Los Angeles, CA 90095 USA.

LEUKEMIA & LYMPHOMA, 2018; 59 (8): 1785

Abstract

The development of clinically functional chimeric antigen receptor (CAR) T cell therapy is the culmination of multiple advances over the last three de......

Full Text Link